TEST

Because lung cancer is not a homogeneous disease...

for actionable mutations inmNSCLC

IDENTIFY

mNSCLC
patients with
BRAF V600
mutation

ACT

with TAFINLAR +
MEKINIST to treat
BRAF V600
mNSCLC

TAFINLAR
Summary of Product Characteristics

MEKINIST
Summary of Product Characteristics